Biblio

De Chiara L, Fagoonee S, Ranghino A, Bruno S, Camussi G, Tolosano E, Silengo L, Altruda F. Renal Cells from Spermatogonial Germline Stem Cells Protect against Kidney Injury. J Am Soc Nephrol. 2013.

• PubMed
• Google Scholar

Henseler O, Heiden M, Haschberger B, Hesse J, Seitz R. [Report on notifications pursuant to §21 German Transfusion Act for 2010 and 2011.]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013.

• PubMed
• Google Scholar

Siemens H, Jackstadt R, Kaller M, Hermeking H. Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget. 2013.

• PubMed
• Google Scholar

Sakurai Y, Kasuda S, Tatsumi K, Takeda T, Kato J, Kubo A, Shima M. Repression of Factor VIII Inhibitor Development with Apoptotic Factor VIII-expressing Embryonic Stem Cells. Hematol Rep. 2013;5(2):30-3.

• PubMed
• Google Scholar

Hung SSC, Wong RCB, Sharov AA, Nakatake Y, Yu H, Ko MSH. Repression of Global Protein Synthesis by Eif1a-Like Genes That Are Expressed Specifically in the Two-Cell Embryos and the Transient Zscan4-Positive State of Embryonic Stem Cells. DNA Res. 2013.

• PubMed
• Google Scholar

Masaki T, McGlinchey A, Tomlinson SR, Qu J, Rambukkana A. Reprogramming diminishes retention of Mycobacterium leprae in Schwann cells and elevates bacterial transfer property to fibroblasts. F1000Res. 2013;2.

• PubMed
• Google Scholar

Montserrat N, Nivet E, Sancho-Martinez I, Hishida T, Kumar S, Miquel L, Cortina C, Hishida Y, Xia Y, Esteban CRodriguez, et al. Reprogramming of human fibroblasts to pluripotency with lineage specifiers. Cell Stem Cell. 2013;13(3):341-50.

• PubMed
• Google Scholar

Pennarossa G, Maffei S, Campagnol M, Rahman MM, Brevini TAL, Gandolfi F. Reprogramming of Pig Dermal Fibroblast into Insulin Secreting Cells by a Brief Exposure to 5-aza-cytidine. Stem Cell Rev. 2013.

• PubMed
• Google Scholar

Pfeiffer MJ, Esteves TC, Balbach ST, Araúzo-Bravo MJ, Stehling M, Jauch A, Houghton FD, Schwarzer C, Boiani M. Reprogramming of two somatic nuclei in the same ooplasm leads to pluripotent embryonic stem cells. Stem Cells. 2013.

• PubMed
• Google Scholar

Akinci E, Banga A, Tungatt K, Segal J, Eberhard D, Dutton JR, Slack JMW. Reprogramming of Various Cell Types to a Beta-Like State by Pdx1, Ngn3 and MafA. PLoS One. 2013;8(11):e82424.

• PubMed
• Google Scholar

Li Y, Shen Z, Shelat H, Geng Y-J. Reprogramming somatic cells to pluripotency: A fresh look at Yamanaka's model. Cell Cycle. 2013;12(23).

• PubMed
• Google Scholar

Moriguchi H, Madson J. The reprogramming therapy for a patient with advanced hepatocellular carcinoma by using human-induced pluripotent stem (iPS) cells technology. BMJ Case Rep. 2013;2013.

• PubMed
• Google Scholar

Marthaler AG, Tiemann U, Araúzo-Bravo MJ, Wu G, Zaehres H, Hyun JKeun, Han DWook, Schöler HR, Tapia N. Reprogramming to Pluripotency through a Somatic Stem Cell Intermediate. PLoS One. 2013;8(12):e85138.

• PubMed
• Google Scholar

Gao X, Yang J, Tsang JCH, Ooi J, Wu D, Liu P. Reprogramming to Pluripotency Using Designer TALE Transcription Factors Targeting Enhancers. Stem Cell Reports. 2013;1(2):183-97.

• PubMed
• Google Scholar

McCormack MP, Shields BJ, Jackson JT, Nasa C, Shi W, Slater NJ, Tremblay CS, Rabbitts TH, Curtis DJ. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. Blood. 2013.

• PubMed
• Google Scholar

Mohri T, Ueno M, Nagahama Y, Gong Z-Y, Asano M, Oshima H, Oshima M, Fujio Y, Takakura N. Requirement of SLD5 for Early Embryogenesis. PLoS One. 2013;8(11):e78961.

• PubMed
• Google Scholar

Qu ZW, Meng QG, Xiao X, Li BL, Zhang FM. Research of Arginylglycylaspartic to Promote osteogenesis of Bone Marrow Mesenchymal Cells on Chitosan/Hydroxyapatite Scaffolds. Biomed Mater Eng. 2013;23:S703-S713.

• PubMed
• Google Scholar

Wang J-F, Liu C, Zhang Q, Huang G-H. Research progress in the radioprotective effect of the canonical Wnt pathway. Cancer Biol Med. 2013;10(2):61-71.

• PubMed
• Google Scholar

Gao J, Inagaki Y, Liu Y. Research progress on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer's disease. Intractable Rare Dis Res. 2013;2(1):3-10.

• PubMed
• Google Scholar

He F-H, Zhu B-Y, Gao F, Li S-S, Li N-H. [Research progress on the cloning of Mendel's gene in pea (Pisum sa-tivum L.) and its application in genetics teaching.]. Yi Chuan. 2013;35(7):931-938.

• PubMed
• Google Scholar

Wang J, Deng L, Lu Y. [Research progresses in cancer stem cell and its vascular microenvironment]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013;30(3):675-8.

• PubMed
• Google Scholar

Zamani Y, Rabiee M, Shokrgozar MAli, Bonakdar S, Tahriri M. Response of Human Mesenchymal Stem Cells to Patterned and Randomly Oriented Poly(Vinyl Alcohol) Nano-fibrous Scaffolds Surface-Modified with Arg-Gly-Asp (RGD) Ligand. Appl Biochem Biotechnol. 2013.

• PubMed
• Google Scholar

Jacobsen ED. Restoring Antitumor Immunity via PD-1 Blockade After Autologous Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2013.

• PubMed
• Google Scholar

Kantarjian H, Thomas D, Jorgensen J, Kebriaei P, Jabbour E, Rytting M, York S, Ravandi F, Garris R, Kwari M, et al. Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia. Cancer. 2013.

• PubMed
• Google Scholar

Shen Y-A, Lin C-H, Chi W-H, Wang C-Y, Hsieh Y-T, Wei Y-H, Chen Y-J. Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation. Evid Based Complement Alternat Med. 2013;2013:590393.

• PubMed
• Google Scholar